Ana Moreno-Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Moreno-Pérez has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Angela Wirth
Institute of Pharmacology, Heidelberg University, Heidelberg, Germany
1 shared publication- Anouar Belkacemi
Institute of Pharmacology, Heidelberg University, Heidelberg, Germany
1 shared publication Bert Klebl
Lead Discovery Center GmbH, Dortmund, Germany
1 shared publicationChristin Richter
Institute of Pharmacology, Heidelberg University, Heidelberg, Germany
1 shared publicationDieter Bruns
Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany
1 shared publication- Frank Zufall
Center for Integrative Physiology and Molecular Medicine, Saarland University, Homburg, Germany
1 shared publication
Latest Publications
- Open Access
- 7 October 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (23) , 5813-5836
TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia
Hypoglycemia triggers autonomic and endocrine counter-regulatory responses to restore glucose homeostasis, a response that is impaired in patients with diabetes and its long-term complication hypoglycemia-associated autonomic failure (HAAF). We show that insulin-evoked hypoglycemia is severely aggravated in mice lacking the cation channel proteins TRPC1, TRPC4, TRPC5, and TRPC6, which cannot be explained by alterations in glucagon or glucocorticoid action. By using various TRPC compound knockout mouse lines, we pinpointed the failure in sympathetic counter-regulation to the lack of the TRPC5 channel subtype in adrenal chromaffin cells, which prevents proper adrenaline rise in blood plasma. Using electrophysiological analyses, we delineate a previously unknown signaling pathway in which stimulation of PAC1 or muscarinic receptors activates TRPC5 channels in a phospholipase-C-dependent manner to induce sustained adrenaline secretion as a crucial step in the sympathetic counter response to insulin-induced hypoglycemia. By comparing metabolites in the plasma, we identified reduced taurine levels after hypoglycemia induction as a commonality in TRPC5-deficient mice and HAAF patients.
- 7 October 2024
- Published by Springer Nature in The EMBO Journal
- Vol. 43 (23) , 5813-5836
Open AccessTRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia
Hypoglycemia triggers autonomic and endocrine counter-regulatory responses to restore glucose homeostasis, a response that is impaired in patients with diabetes and its long-term complication hypoglycemia-associated autonomic failure (HAAF). We show that insulin-evoked hypoglycemia is severely aggravated in mice lacking the cation channel proteins TRPC1, TRPC4, TRPC5, and TRPC6, which cannot be explained by alterations in glucagon or glucocorticoid action. By using various TRPC compound knockout mouse lines, we pinpointed the failure in sympathetic counter-regulation to the lack of the TRPC5 channel subtype in adrenal chromaffin cells, which prevents proper adrenaline rise in blood plasma. Using electrophysiological analyses, we delineate a previously unknown signaling pathway in which stimulation of PAC1 or muscarinic receptors activates TRPC5 channels in a phospholipase-C-dependent manner to induce sustained adrenaline secretion as a crucial step in the sympathetic counter response to insulin-induced hypoglycemia. By comparing metabolites in the plasma, we identified reduced taurine levels after hypoglycemia induction as a commonality in TRPC5-deficient mice and HAAF patients.